September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Effect of Complement Factor H Variants in Regulating AMD-like Pathologies In Vivo.
Author Affiliations & Notes
  • Michael Landowski
    Ophthalmology , Duke University, Durham, North Carolina, United States
  • Jindong Ding
    Ophthalmology , Duke University, Durham, North Carolina, United States
  • Mikael Klingeborn
    Ophthalmology , Duke University, Durham, North Carolina, United States
  • Una Kelly
    Ophthalmology , Duke University, Durham, North Carolina, United States
  • Marybeth Groelle
    Ophthalmology , Duke University, Durham, North Carolina, United States
  • Catherine Bowes Rickman
    Ophthalmology , Duke University, Durham, North Carolina, United States
    Cell Biology, Duke University, Durham, North Carolina, United States
  • Footnotes
    Commercial Relationships   Michael Landowski, None; Jindong Ding, None; Mikael Klingeborn, None; Una Kelly, None; Marybeth Groelle, None; Catherine Bowes Rickman, None
  • Footnotes
    Support  NEI P30 EY005722; NEI R01 EY019038 and Research to Prevent Blindness
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 6526. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Michael Landowski, Jindong Ding, Mikael Klingeborn, Una Kelly, Marybeth Groelle, Catherine Bowes Rickman; Effect of Complement Factor H Variants in Regulating AMD-like Pathologies In Vivo.
      . Invest. Ophthalmol. Vis. Sci. 2016;57(12):6526.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The Y402H polymorphism in the complement factor H (CFH gene, FH protein) is associated with increased risk for age-related macular degeneration (AMD), but the role of the risk-associated H402 variant in AMD remains unclear. We generated transgenic mouse lines expressing the same concentration of full-length human normal Y402 or risk-associated H402 variants of the FH protein on a mouse Cfh knockout background (CFH-Y:Cfh-/- and CFH-HH:Cfh-/-, respectively) to mechanistically study the function of FH variants in AMD pathogenesis in vivo. We tested the hypotheses (1) that an AMD-like phenotype will develop in old CFH:Cfh-/- mice following 8 weeks on a high fat, cholesterol-enriched (HFC) diet and (2) that there is a variant-associated difference in the amount of sub-RPE deposit, visual loss, and RPE damage between these lines.

Methods : 90 week-old male C57BL/6J, CFH-Y:Cfh-/-, CFH-HH:Cfh-/- and Cfh-/- mice were housed conventionally, under ambient conditions and maintained on water ad libitum and fed either a normal mouse chow diet (ND) or switched to a HFC diet for 8 wks. ERGs and plasma samples were obtained prior to termination. Eyes were collected and processed for electron microscopy for quantification of sub-RPE deposit load, immunofluorescence to assess RPE damage and routine histology.

Results : Old mice expressing only human FH that were fed a HFC diet developed vision loss, larger sub-RPE deposits, and more multinucleated RPE cells compared to their age-matched, normal diet controls. As we have previously shown, aged Cfh-/- mice did not develop an AMD-like phenotype following HFC diet. The phenotype in CFH-Y:Cfh-/- mice fed a HFC diet appears to be less severe than in the CFH-HH:Cfh-/- mice fed a HFC diet.

Conclusions : CFH-Y:Cfh-/- and CFH-HH:Cfh-/- mice on HFC diet develop an AMD-like phenotype. The less severe AMD-like phenotype observed in aged CFH-Y:Cfh-/- mice on HFC diet compared to aged CFH-HH:Cfh-/- mice on HFC diet suggests that the Y402 variant is protective against AMD-like pathology. These models will be useful in elucidating the molecular mechanisms underlying the association of the H402 variant with AMD risk.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×